Kefzol Stungulyfs-/innrennslisstofn, lausn 1 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

kefzol stungulyfs-/innrennslisstofn, lausn 1 g

stada nordic aps. - cefazolinum natríum - stungulyfs-/innrennslisstofn, lausn - 1 g

Lytgobi Evrópusambandið - íslenska - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic lyfjum - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.